|From: NetworkNewsWire (Rep: 0)||Date: 06/08/2018 18:30|
|Forum: Penny Stocks - Msg #1724 - List LXRP msgs ||Thread #674014236 (Rec: 0) |
|NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH Delivers Improved Absorption and Application Versatility|
Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) DehydraTECH™ enables improved bioabsorption and versatility in drug delivery applications. A recent article discussing the company’s unique technology reads: “DehydraTECH™ is a unique enabling technology from Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) that increases the absorption rate of edible ingestion, delivering five to 10 times more of active ingredients than traditional edibles. This technology is not a competing technology but rather a complementary layer that provides a versatile range of commercial applications. LXRP is the only company in the world that has been awarded a patent for the improved (oral or ingestible) delivery of all non-psychoactive cannabinoids in the U.S. and Australia, and the company has 40 more patents pending worldwide. DehydraTECH™ is patented or patent pending for use with a broad range of bioactive molecules. There are many potential uses for this technology, which aims to enhance ingestible products in terms of taste, smell, speed of action, bioabsorption and bioavailability.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.